Arbuscular mycorrhiza

Kaufman & Broad SA: Dividend payment 2021

Retrieved on: 
Thursday, May 6, 2021

b'About Kaufman & Broad - Kaufman & Broad has been designing, developing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.

Key Points: 
  • b'About Kaufman & Broad - Kaufman & Broad has been designing, developing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.
  • Kaufman & Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.\nThe Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No.
  • It is available on the AMF ( www.amf-france.org ) and Kaufman & Broad ( www.kaufmanbroad.fr ) websites.
  • Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 4 of the Registration Document.

NANOBIOTIX Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F

Retrieved on: 
Wednesday, April 7, 2021

In addition, the 2020 universal registration document is available on the AMF website ( www.amf-france.org ) and the 2020 Annual Report on Form 20-F is available on the SEC website ( www.sec.gov ).

Key Points: 
  • In addition, the 2020 universal registration document is available on the AMF website ( www.amf-france.org ) and the 2020 Annual Report on Form 20-F is available on the SEC website ( www.sec.gov ).
  • In particular, the Companys 2020 universal registration document includes its:
    Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity.
  • Incorporated in 2003, Nanobiotix is headquartered in Paris and also has subsidiaries in France, Spain, and Germany.
  • Such forward-looking statements are made in light of information currently available to us and based on assumptions that Nanobiotix considers to be reasonable.

Connext Joins AMF Media Group

Retrieved on: 
Monday, January 25, 2021

SAN RAMON, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- AMF Media Group (AMF) , an award-winning, full-service marketing agency, today announced that the team from communications consultancy Connext will join AMF effective February 1, 2021.

Key Points: 
  • SAN RAMON, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- AMF Media Group (AMF) , an award-winning, full-service marketing agency, today announced that the team from communications consultancy Connext will join AMF effective February 1, 2021.
  • Going forward, Connext Services will be a new service offered by AMF Media Group.
  • If the events of 2020 showed us anything, its that the market is looking for a more nimble and holistic service model, said Vintage Foster, CEO of AMF Media Group.
  • Shandy Dunn, who is currently president of Connext, will become president of the Connext Services division of AMF Media Group.

Kaufman & Broad SA: Half-year Liquidity contract

Retrieved on: 
Thursday, January 7, 2021

About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.

Key Points: 
  • About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.
  • Kaufman&Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.
  • This press release is prepared in accordance with Articles 212-4, 5 and 212-5, 6 of the General Regulation of the AMF and the Article 19 of AMF Official Line DOC-2016-14.

Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory

Retrieved on: 
Thursday, November 19, 2020

Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, is expanding its research collaboration with parent company Sumitomo Chemical Co., Ltd. by establishing a dedicated Biorational Research Unit at Sumitomo Chemicals Health & Crop Sciences Research Laboratory (HCRL) in Takarazuka, Hyogo, Japan.

Key Points: 
  • Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, is expanding its research collaboration with parent company Sumitomo Chemical Co., Ltd. by establishing a dedicated Biorational Research Unit at Sumitomo Chemicals Health & Crop Sciences Research Laboratory (HCRL) in Takarazuka, Hyogo, Japan.
  • The enhanced partnership, which includes the addition of technical staff with expertise in a broad variety of areas, begins on December 1.
  • Initially, the Biorational Research Unit at the HCRL will focus on biopesticide discovery, field application of plant growth regulators (PGRs) in Japan, and various projects related to arbuscular mycorrhizal fungi (AMF).
  • As the groups technical capabilities and expertise increase, Valent BioSciences will continue expanding its range of research activities.

Pharnext 2019 Universal Registration Document Approved by AMF

Retrieved on: 
Tuesday, November 10, 2020

PARIS, France, 08:30 a.m. CET, November 10, 2020 - Pharnext SA (FR0011191287 - ALPHA), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence ("Company") using its PLEOTHERAPY(TM) platform, today announced that its 2019 Universal Registration Document has been approved by the Autorit des Marchs Financiers (AMF) on November 9, 2020 under number N R. 20-029.

Key Points: 
  • PARIS, France, 08:30 a.m. CET, November 10, 2020 - Pharnext SA (FR0011191287 - ALPHA), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence ("Company") using its PLEOTHERAPY(TM) platform, today announced that its 2019 Universal Registration Document has been approved by the Autorit des Marchs Financiers (AMF) on November 9, 2020 under number N R. 20-029.
  • The Universal Registration Document is available to the public, in English only, on Pharnext website at www.pharnext.com , under Investors/Regulated Information and also on the AMF website at www.amf-france.org .
  • Copies of this Universal Registration Document are available free of charge from Pharnext (46, rue Saint-Lazare 75009 Paris).
  • The forward-looking statements contained in this press release are also subject to risks not yet known to Pharnext or not currently considered material by Pharnext.

Kaufman & Broad SA: IMPLEMENTATION OF THE SHARE BUY-BACK PROGRAM

Retrieved on: 
Wednesday, July 22, 2020

The Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No.

Key Points: 
  • The Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No.
  • It is available on the AMF ( www.amf-france.org ) and Kaufman & Broad ( www.kaufmanbroad.fr ) websites.
  • It contains a detailed description of Kaufman & Broad's business activities, results, and outlook, as well as the associated risk factors.
  • Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 1.2 of the Registration Document.

INGENICO GROUP: Worldline filed its proposed tender offer for Ingenico securities with the Autorité des marchés financiers (AMF) - Ingenico's board of directors issued a favorable reasoned opinion on the offer

Retrieved on: 
Wednesday, July 8, 2020

Today, we have achieved an important step in the creation of the new European World-Class leader in digital payments.

Key Points: 
  • Today, we have achieved an important step in the creation of the new European World-Class leader in digital payments.
  • It is recalled that Bpifrance Participations has also undertaken to tender its Ingenico shares, representing 5.31% of Ingenico's capital, to the tender offer.
  • Worldline's draft offer document and Ingenico's reply offer document are available on the AMF website ( www.amf-france.org ), as well as on the websites of Worldline ( www.fr.worldline.com ) and Ingenico ( www.ingenico.com ).
  • The tender offer and the draft offer document remain subject to review by the AMF, which will assess their compliance with applicable laws and regulations.

Kaufman & Broad SA: Half-year Liquidity contract

Retrieved on: 
Friday, July 3, 2020

About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.

Key Points: 
  • About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.
  • Kaufman&Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.
  • This press release is prepared in accordance with Articles 212-4, 5 and 212-5, 6 of the General Regulation of the AMF and the Article 19 of AMF Official Line DOC-2016-14.

Kaufman & Broad SA: Press Release

Retrieved on: 
Sunday, April 19, 2020

About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.

Key Points: 
  • About Kaufman & Broad - Kaufman&Broad has been designing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years.
  • The Kaufman & Broad Universal Registration Document was filed with the French Financial Markets Authority ("AMF") under No.
  • It is available on the AMF ( www.amf-france.org ) and Kaufman & Broad ( www.kaufmanbroad.fr ) websites.
  • Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 1.2 of the Universal Registration Document.